Beryl Drugs share price
You have to be logged in to add this to Watchlist.- ₹20.10(0.00%)May 20, 2026 13:02:30 PM IST
- NSE
- BSE
- Vol : 0.24 K (NSE + BSE)Last 20 day avg : 2.09 K
Beryl Drugs is trading 0.00% upper at Rs 20.10 as compared to its last closing price. Beryl Drugs has been trading in the price range of 20.15 & 20.10. Beryl Drugs has given -14.10% in this year & -1.95% in the last 5 days. Beryl Drugs has TTM P/E ratio 774.32 as compared to the sector P/E of 25.16.The company posted a net profit of -0.17 Crores in its last quarter.Listed peers of Beryl Drugs include Sun Pharmaceutical Industries (-0.44%), Divi's Laboratories (-0.98%), Torrent Pharmaceuticals (-0.98%).The Mutual Fund holding in Beryl Drugs was at -% in . The MF holding has - from the last quarter. The FII holding in Beryl Drugs was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 20, 2026, 08:03 AM UTC
- BetaMedium volatility0.92Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.43The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values1.07The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values665.12Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation10.30The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,873.95 | -0.44 | 4,49,576.95 | 37.99 | 6.05 | 0.91 | 0.50 |
| Divi's Laboratories | Bullish | 6,845.00 | -0.98 | 1,81,532.04 | 80.48 | 11.8 | 0.45 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,413.45 | -0.98 | 1,49,365.20 | 75.06 | 19.06 | 0.82 | 17.62 |
| Cipla | Moderately Bullish | 1,403.20 | -0.47 | 1,13,331.99 | 20.46 | 3.45 | 0.97 | 0.81 |
| Lupin | Neutral | 2,285.00 | -0.07 | 1,04,473.83 | 32.01 | 6.22 | 0.51 | 11.80 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-04-01 | Notice of EGM & Others |
| 2026-02-09 | Quarterly Results |
| 2026-01-03 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-09-02 | A.G.M. |
- IndustryBiotechnology & Drugs
- ISININE415H01017
- BSE Code524606
- NSE Code
Beryl Drugs is trading at 20.10 as on Wed May 20 2026 07:32:30. This is 0.00% upper as compared to its previous closing price of 20.10.
The market capitalization of Beryl Drugs is 10.19 Cr as on Wed May 20 2026 07:32:30.
The 52 wk high for Beryl Drugs is 30.00 whereas the 52 wk low is 15.92
Beryl Drugs can be analyzed on the following key metrics -
- TTM P/E: 774.32
- Sector P/E: 25.16
- Dividend Yield: 0.00%
- D/E ratio: -
Beryl Drugs reported a net profit of 0.58 Cr in 2025.
EQUITY QUICK LINKS
Beryl Drugs QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.